Major progress in drug review and evaluation in 2022

Home> Policies Interpretation

Major progress in drug review and evaluation in 2022

Updated: 2023-11-14

01-800x3500(4).jpg

1 2 3 ... 5 >

Policies Interpretation

Policy interpretation of the NMPA Announcement on Measures to Optimize the Management of Safety Assessment of Cosmetics
Major progress in drug review and evaluation in 2022
First China-led international standard for COVID-19 prevention and control medical devices